The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping …

The Daily Biotech Pulse: Exelixis Liver Cancer Drug On Track For European Approval, Medtronic Goes Shopping …

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 20.) Abbott Laboratories (NYSE: ABT) Acceleron Pharma Inc (NASDAQ: XLRN) Amgen, Inc. (NASDAQ: AMGN) AtriCure Inc. (NASDAQ: ATRC) Baxter International Inc (NYSE: BAX) Cara Therapeutics Inc (NASDAQ: CARA) […]

Celgene passes on OncoMed cancer drug, biotech's shares tank

Celgene passes on OncoMed cancer drug, biotech's shares tank

Celgene has decided against taking an option on Oncomed’s cancer drug navicixizumab, sending the California biotech’s shares into freefall. Following the announcement Oncomed’s value fell by nearly 14% on the Nasdaq following the news that Celgene had passed on the option to take a licence on the anti DLL4/VEGF bispecific antibody. Celgene retains its options […]

Sloan Kettering's Cozy Deal With Start-Up Ignites a New Uproar

Sloan Kettering's Cozy Deal With Start-Up Ignites a New Uproar

This article was reported and written in a collaboration with ProPublica, the nonprofit investigative journalism organization. An artificial intelligence start-up founded by three insiders at Memorial Sloan Kettering Cancer Center debuted with great fanfare in February, with $25 million in venture capital and the promise that it might one day transform how cancer is diagnosed. […]

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world’s most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications. Scientists from the University of Melbourne and the Japanese pharmaceutical company Takeda have discovered that antimalarial drug artemisinin works through a “double whammy” […]

Improved cancer drug access hailed

Improved cancer drug access hailed

Published: 17:35 Thursday 20 September 2018 The SDLP’s Mark H. Durkan has welcomed plans to improved access to specialist cancer drugs in the North. He said: “The current situation where some patients in NI are offered a second class service compared to those in England is unfair and it […]

Big Jump in US Spending on Cancer Drugs From 2011 to 2016

Big Jump in US Spending on Cancer Drugs From 2011 to 2016

Total expenditures for cancer drugs, including new immunotherapies and targeted agents, in the United States jumped from $26.8 billion in 2011 to $42.1 billion in 2016. During the same period, the US Food and Drug Administration approved 52 new cancer therapies. The findings come from a unique study published online September 18 in the Journal […]

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

IMAGE: The antimalarial drug, artemisinin packs a double whammy — exploding inside malaria parasites and shutting down the waste disposal system that deals with the damage. Resistance to artemisinin, can be… view more  Credit: Dr Eric Hanssen Scientists have found a way to boost the efficacy of the world’s most powerful antimalarial drug with the help […]

Drug treatment for rare blood cancer will save more lives

Drug treatment for rare blood cancer will save more lives

A drug aimed at treating an aggressive disease that affects the blood and bone marrow is set to save more lives, with the medication now available for more patients on the Pharmaceutical Benefits Scheme (PBS). People who suffer from Chronic Myeloid Leukaemia (CML) can access ICLUSIG, also known as ponatinib. As of this month it is now […]

New cancer drug tested on beagle with view to curing prostate cancer

New cancer drug tested on beagle with view to curing prostate cancer

Hoover the beagle has undergone a revolutionary new method for treating prostate cancer – there’s only one difference, it’s forms part of a treatment usually reserved for humans. The canine was injected with new anti-nanotherapy at the University of Queensland as part of a clinical trial aimed at eventually finding a cure for prostate cancer […]